Matthew M. Gosling

2014

In 2014, Matthew M. Gosling earned a total compensation of $1.4M as Senior Vice President and General Counsel at DepoMed, a 51% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$188,407
Option Awards$392,122
Salary$396,596
Stock Awards$444,150
Other$7,586
Total$1,428,861

Gosling received $444.2K in stock awards, accounting for 31% of the total pay in 2014.

Gosling also received $188.4K in non-equity incentive plan, $392.1K in option awards, $396.6K in salary and $7.6K in other compensation.

Rankings

In 2014, Matthew M. Gosling's compensation ranked 5,988th out of 13,032 executives tracked by ExecPay. In other words, Gosling earned more than 54.1% of executives.

ClassificationRankingPercentile
All
5,988
out of 13,032
54th
Division
Manufacturing
2,165
out of 4,965
56th
Major group
Chemicals And Allied Products
718
out of 1,690
58th
Industry group
Drugs
558
out of 1,369
59th
Industry
Pharmaceutical Preparations
431
out of 1,042
59th
Source: SEC filing on July 14, 2017.

Gosling's colleagues

We found five more compensation records of executives who worked with Matthew M. Gosling at DepoMed in 2014.

2014

James Schoeneck

DepoMed

Chief Executive Officer

2014

Thadd Vargas

DepoMed

Senior Vice President, Business Development

2014

August Moretti

DepoMed

Chief Financial Officer

2014

R Shively

DepoMed

Former Senior Vice President and Chief Commercial Officer

2014

Srinivas Rao

DepoMed

Chief Medical Officer

News

You may also like